ClinicalThought

Share

Program Content

Activities

  • Targeting BCMA in R/R MM
    Current Strategies for Targeting BCMA in R/R Myeloma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: September 09, 2021

    Expires: September 08, 2022

  • R/R MM: Anti-BCMA Tx
    FAQs on the Use of BCMA-Targeted Therapies for Relapsed or Refractory Multiple Myeloma
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: October 29, 2021

    Expires: October 28, 2022

Faculty

cover img faculity

Suzanne Lentzsch, MD, PhD

Director, Multiple Myeloma and Amyloidosis Program
Associate Professor of Medicine
Division of Hematology/Oncology
Columbia University Medical Center
New York, New York

cover img faculity

Sagar Lonial, MD, FACP

Chair and Professor 
Department of Hematology and Medical Oncology
Anne and Bernard Gray Family Chair in Cancer
Chief Medical Officer
Winship Cancer Institute
Emory University School of Medicine
Atlanta, Georgia

cover img faculity

Thomas G. Martin, MD

Associate Clinical Professor of Medicine
Associate Director
, Myeloma Institute
University of California, San Francisco Medical Center
San Francisco, California

Provided by

ProCE Banner

Supporters

GlaxoSmithKline

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC